127 related articles for article (PubMed ID: 26425978)
1. Stability and toxicity of tris-tolyl bismuth(V) dicarboxylates and their biological activity towards Leishmania major.
Ong YC; Blair VL; Kedzierski L; Tuck KL; Andrews PC
Dalton Trans; 2015 Nov; 44(41):18215-26. PubMed ID: 26425978
[TBL] [Abstract][Full Text] [Related]
2. Anti-leishmanial activity of heteroleptic organometallic Sb(v) compounds.
Ali MI; Rauf MK; Badshah A; Kumar I; Forsyth CM; Junk PC; Kedzierski L; Andrews PC
Dalton Trans; 2013 Dec; 42(48):16733-41. PubMed ID: 24077559
[TBL] [Abstract][Full Text] [Related]
3. Stability and toxicity of heteroleptic organometallic Bi(V) complexes towards Leishmania major.
Ong YC; Blair VL; Kedzierski L; Andrews PC
Dalton Trans; 2014 Sep; 43(34):12904-16. PubMed ID: 25019320
[TBL] [Abstract][Full Text] [Related]
4. Comparative stability, toxicity and anti-leishmanial activity of triphenyl antimony(v) and bismuth(v) α-hydroxy carboxylato complexes.
Duffin RN; Blair VL; Kedzierski L; Andrews PC
Dalton Trans; 2018 Jan; 47(3):971-980. PubMed ID: 29260831
[TBL] [Abstract][Full Text] [Related]
5. Anti-Leishmanial activity of homo- and heteroleptic bismuth(III) carboxylates.
Andrews PC; Frank R; Junk PC; Kedzierski L; Kumar I; MacLellan JG
J Inorg Biochem; 2011 Mar; 105(3):454-61. PubMed ID: 20851471
[TBL] [Abstract][Full Text] [Related]
6. Comparative stability, cytotoxicity and anti-leishmanial activity of analogous organometallic Sb(V) and Bi(V) acetato complexes: Sb confirms potential while Bi fails the test.
Duffin RN; Blair VL; Kedzierski L; Andrews PC
J Inorg Biochem; 2018 Dec; 189():151-162. PubMed ID: 30267965
[TBL] [Abstract][Full Text] [Related]
7. Bismuth(III) α-hydroxy carboxylates: highly selective toxicity of glycolates towards Leishmania major.
Loh A; Ong YC; Blair VL; Kedzierski L; Andrews PC
J Biol Inorg Chem; 2015 Oct; 20(7):1193-203. PubMed ID: 26411702
[TBL] [Abstract][Full Text] [Related]
8. Structural influences on the activity of bismuth(III) indole-carboxylato complexes towards Helicobacter pylori and Leishmania.
Pathak A; Blair VL; Ferrero RL; Kedzierski L; Andrews PC
J Inorg Biochem; 2017 Dec; 177():266-275. PubMed ID: 28583712
[TBL] [Abstract][Full Text] [Related]
9. Bismuth(III) β-thioxoketonates as antibiotics against Helicobacter pylori and as anti-leishmanial agents.
Andrews PC; Blair VL; Ferrero RL; Junk PC; Kedzierski L; Peiris RM
Dalton Trans; 2014 Jan; 43(3):1279-91. PubMed ID: 24190067
[TBL] [Abstract][Full Text] [Related]
10. A new class of oxo-bridged high-valent hexamanganese clusters supported by sterically hindered carboxylate ligands.
Mukhopadhyay S; Gandhi BA; Kirk ML; Armstrong WH
Inorg Chem; 2003 Dec; 42(25):8171-80. PubMed ID: 14658867
[TBL] [Abstract][Full Text] [Related]
11. Sterically hindered carboxylate ligands support water-bridged dimetallic centers that model features of metallohydrolase active sites.
Lee D; Hung PL; Spingler B; Lippard SJ
Inorg Chem; 2002 Feb; 41(3):521-31. PubMed ID: 11825079
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization, and preliminary oxygenation studies of benzyl- and ethyl-substituted pyridine ligands of carboxylate-rich diiron(II) complexes.
Carson EC; Lippard SJ
Inorg Chem; 2006 Jan; 45(2):828-36. PubMed ID: 16411721
[TBL] [Abstract][Full Text] [Related]
13. Structural diversity in supramolecular complexes of MCl(3) (M = As, Sb, Bi) with constrained thio- and seleno-ether ligands.
Levason W; Maheshwari S; Ratnani R; Reid G; Webster M; Zhang W
Inorg Chem; 2010 Oct; 49(19):9036-48. PubMed ID: 20812749
[TBL] [Abstract][Full Text] [Related]
14. Anti-leishmanial activity and cytotoxicity of a series of tris-aryl Sb(V) mandelate cyclometallate complexes.
Duffin RN; Blair VL; Kedzierski L; Andrews PC
J Inorg Biochem; 2020 Feb; 203():110932. PubMed ID: 31790875
[TBL] [Abstract][Full Text] [Related]
15. Newly designed organotin(IV) carboxylates with peptide linkage: Synthesis, structural elucidation, physicochemical characterizations and pharmacological investigations.
Sirajuddin M; McKee V; Tariq M; Ali S
Eur J Med Chem; 2018 Jan; 143():1903-1918. PubMed ID: 29133050
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of bismuth(III) and antimony(V) porphyrins: high antileishmanial activity against antimony-resistant parasite.
Gomes ML; DeFreitas-Silva G; dos Reis PG; Melo MN; Frézard F; Demicheli C; Idemori YM
J Biol Inorg Chem; 2015 Jul; 20(5):771-9. PubMed ID: 25929728
[TBL] [Abstract][Full Text] [Related]
17. Structural motifs in phenylbismuth heterocyclic carboxylates--secondary interactions leading to oligomers.
Anjaneyulu O; Maddileti D; Kumara Swamy KC
Dalton Trans; 2012 Jan; 41(3):1004-12. PubMed ID: 22105914
[TBL] [Abstract][Full Text] [Related]
18. Do bismuth complexes hold promise as antileishmanial drugs?
Ong YC; Kedzierski L; Andrews PC
Future Med Chem; 2018 Jul; 10(14):1721-1733. PubMed ID: 29961352
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structural characterisation of bismuth(III) hydroxamates and their activity against Helicobacter pylori.
Pathak A; Blair VL; Ferrero RL; Junk PC; Tabor RF; Andrews PC
Dalton Trans; 2015 Oct; 44(38):16903-13. PubMed ID: 26352159
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and oxidation of carboxylate-bridged diiron(II) complexes with substrates tethered to primary alkyl amine ligands.
Carson EC; Lippard SJ
J Inorg Biochem; 2006 May; 100(5-6):1109-17. PubMed ID: 16439023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
